The new 2018 European guidelines for the treatment of high blood pressure have been jointly developed by the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). The guidelines provide recommendations for doctors across Europe about how to diagnose high blood pressure, evaluate risk, and when and how to treat high blood pressure and reduce risk, with both lifestyle advice and medications.
A first look at the long-awaited guidelines was presented at the ESH meeting in Barcelona last week. The full text of the new joint guidelines for the Management of Arterial Hypertension will be published on 25 August 2018 in parallel with a corresponding presentation during the ESC Congress 2018 in Munich (25-29 August 2018).
The development of the guidelines was led by Prof. Bryan Williams (ESC Chairperson), London UK, and Prof. Giuseppe Mancia (ESH Chairperson), Milan Italy, as lead authors.
"These clinical guidelines are one of the most important in Europe because high blood pressure affects so many people, over 25 percent of the adult population," according to Professor Bryan Williams, University College London. "The focus of the guideline is to improve the treatment of high blood pressure and blood pressure control in treated patients, which at present is not as good as it should be."
Professor Giuseppe Mancia, University Milano-Bicocca Milan, stated: "The 2018 ESC/ESH guidelines issue new recommendations on how to optimally treat hypertension. Drug therapy extends to additional groups of patients. Also, blood pressure values to aim at with treatment are lower than in the past. In addition, combination therapy is now recognised as the most effective initial treatment strategy in most patients."
Image Credit: Pixabay